Neuroscience Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neuroscience

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scott_jiminez who started this subject	3/4/2001 1:53:35 PM
From: scott_jiminez	of 278

Portfolios update It's been nearly 6 weeks since I've updated. Five months since the portfolios were created....a lousy period to own most stocks. The equipment stocks recovered for a while (in fact, the SEM portfolio showed a slight gain a couple of weeks ago) but have imploded again of late following fresh warnings. The biotechs have been in a funk for quite a while with no sustained signs of a recovery yet. The Hubris-biotech portfolio displays the most interesting statistical 'event' among the portfolios: the relative standard deviation of this group is far less than the other two. In other words, the performance of the biotechs shows impressive internal consistency. The fact that eight stocks performed in such close harmony argues against a statistical fluke and in favor of generalized, sector-wide movements in the BTs as a manifest phenomenon. The fact that the Hypertension Diagnostic Warrants (Pariah portfolio) performed almost exactly at the mean of the BT portfolio (during a period when the company announced a string of positive and impressive developments) reinforces this view of the biotech sector. The fact that the biotechs move en massejust like the semi-equipment stocks (and countless other sectors) should come as no surprise. ---------------------------------- Performance since inception (9/28/00): Hubris/SEM: -18.8% (+/- 13.5) Pariah: -34.7% (+/- 32.9) Hubris/Biotech: -55.6% (+/- 6.8) Hubris - SEM LRCX +3.4% KLIC -11.6% KLAC -12.0% TER -13.3% NVLS -17.5% AMAT -28.6% AMKR -35.5% ASML -35.6% Pariah DXT -4.2% SBC -6.3% KLIC -11.6% HDIIW -56.3% MXR -56.5% PTX -81.8% Hubris - Biotech RGEN -48.9% VRTX -49.5% NBIX -50.6% TTP -52.4% MLNM -56.0% NBSC -56.4% SEPR -62.9% BTRN -68.1%

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next